COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?

Corona virus infectious disease (COVID-19) is a new pandemic. In subjects with diabetes mellitus, infection may be more frequent and severe. We discuss the potential contribution of two traditional oral antidiabetic agents, metformin and pioglitazone, to the improvement of liver injury in COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Penlioglou, Theano, Papachristou, Stella, Papanas, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204191/
https://www.ncbi.nlm.nih.gov/pubmed/32382358
http://dx.doi.org/10.1007/s13300-020-00830-0
_version_ 1783530013862133760
author Penlioglou, Theano
Papachristou, Stella
Papanas, Nikolaos
author_facet Penlioglou, Theano
Papachristou, Stella
Papanas, Nikolaos
author_sort Penlioglou, Theano
collection PubMed
description Corona virus infectious disease (COVID-19) is a new pandemic. In subjects with diabetes mellitus, infection may be more frequent and severe. We discuss the potential contribution of two traditional oral antidiabetic agents, metformin and pioglitazone, to the improvement of liver injury in COVID-19. Clearly, further experience is needed to shed light on these hypotheses.
format Online
Article
Text
id pubmed-7204191
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-72041912020-05-07 COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone? Penlioglou, Theano Papachristou, Stella Papanas, Nikolaos Diabetes Ther Letter Corona virus infectious disease (COVID-19) is a new pandemic. In subjects with diabetes mellitus, infection may be more frequent and severe. We discuss the potential contribution of two traditional oral antidiabetic agents, metformin and pioglitazone, to the improvement of liver injury in COVID-19. Clearly, further experience is needed to shed light on these hypotheses. Springer Healthcare 2020-05-07 2020-06 /pmc/articles/PMC7204191/ /pubmed/32382358 http://dx.doi.org/10.1007/s13300-020-00830-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Letter
Penlioglou, Theano
Papachristou, Stella
Papanas, Nikolaos
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
title COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
title_full COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
title_fullStr COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
title_full_unstemmed COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
title_short COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
title_sort covid-19 and diabetes mellitus: may old anti-diabetic agents become the new philosopher’s stone?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204191/
https://www.ncbi.nlm.nih.gov/pubmed/32382358
http://dx.doi.org/10.1007/s13300-020-00830-0
work_keys_str_mv AT penliogloutheano covid19anddiabetesmellitusmayoldantidiabeticagentsbecomethenewphilosophersstone
AT papachristoustella covid19anddiabetesmellitusmayoldantidiabeticagentsbecomethenewphilosophersstone
AT papanasnikolaos covid19anddiabetesmellitusmayoldantidiabeticagentsbecomethenewphilosophersstone

Ejemplares similares